High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer
Explore this paper's citation graph
- Type
- article
- Published
- 2016-07-22
- Cited by
- 20
- References
- 26
- Access
- Open access
- OpenAlex
- https://openalex.org/W2482126832
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:19302738
Keywords
Medicine, Internal medicine, Hazard ratio, Colorectal cancer, Proportional hazards model
References
- NCCN Clinical Practice Guidelines in Oncology: colon cancer.
- Adjuvant chemotherapy use and outcomes of patients with high‐risk versus low‐risk stage II colon cancer
- Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.
- Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group.
- Clinically important aspects of lymph node assessment in colon cancer
- The role of adjuvant chemotherapy in stage II colorectal cancer patients
- Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer
- Dilemma of stage II colon cancer and decision making for adjuvant chemotherapy.
- Adjuvant chemotherapy for stage II colon cancer with poor prognostic features.
- Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.
- Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
- Population-based differences in treatment outcome following anticancer drug therapies.
- American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
- Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials.
- Capecitabine as adjuvant treatment for stage III colon cancer.
- Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature
- Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.
- Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging.
- Identification of Patients with High-Risk Stage II Colon Cancer for Adjuvant Therapy
- Changing treatment patterns in elderly patients with resectable colon cancer
Cited by
- Prognostic Factors Analysis for Colon Cancer with Lymph Node Negative.
- Need for adjuvant chemotherapy after colon cancer surgery – has it decreased?
- Stromal Expression of Vimentin Predicts the Clinical Outcome of Stage II Colorectal Cancer for High-Risk Patients
- High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal
- Long-term outcome after one-stage surgery without preoperative decompression for stage II/III malignant colorectal obstruction: a propensity score-matched analysis
- Patient Selection for Adjuvant Chemotherapy in High-Risk Stage II Colon Cancer
- Impact of high-risk features for stage II adenocarcinoma of the appendix.
- Better survival of right-sided than left-sided stage II colon cancer: a propensity scores matching analysis based on SEER database.
- Metachronous metastasis confined to isolated lymph node after curative treatment of colorectal cancer
- Tumor Sidedness Could be a Prognostic Factor in Patients with Stage II Colon Cancer
- Tumor Sidedness Could be a High-risk Factor in Patients with Stage II Colon Cancer
- Prognostic impact of tumour sidedness in patients with stage II colon cancer: a single‐centre retrospective study
- Multiple High-Risk Features for Stage II Colon Carcinoma Portends Worse Survival Than Stage III Disease
- Predictive Value of Circulating Tumor Cells Based on Subtraction Enrichment for Recurrence Risk in Stage II Colorectal Cancer.
- Risk factors for postoperative recurrence in patients with stage II colorectal cancer
- Stratification of Stage II Colon Cancer Using Recurrence Prediction Value
- In-depth analysis of lymph node metastasis-related sialylated protein profiling and their clinical and biological significance in colorectal cancer using mass spectrometry and multi-omics technologies
- Elevated CA19-9 within the normal range suggests poorer prognosis in stage II CRC: A retrospective analysis of a large sample in a single center.
- Genomic Signatures of Recurrence After Resection of Early-Stage Node-Negative Colon Cancer
- Impact of adjuvant chemotherapy on survival outcomes in older and non-older patients with high-risk stage II colorectal cancer
Related papers
- Clinicopathological Study of Endemic Goiter
- Expression of PTTG and its significance in colorectal cancer
- Fichandler Stage, Arena Stage
- [New criteria for bladder tumor staging by computed tomography (author's transl)].
- Correlation between the expression of the BAG-1 gene and clinicopathologic factors in colorectal cancer
- δ-catenin Expression Correlates with Cell Proliferation in Colorectal Cancer
- Prognostic Significance of COX-2 Immunohistochemical Expression in Colorectal Cancer: A Meta-Analysis of the Literature
- 059 Secondary progressive MS in the UK: a prospective cohort study